Filtered Listing Testing
An oral supplement to treat advanced AMD, gene therapy for eye diseases, 5 clinical trial myth busters, summaries of 2 of the 18 new grants Macular Degeneration Research recently awarded to help fight AMD, and more are found in the fall 2018 edition of Macular Degeneration Research News.
BrightFocus Foundation, a Maryland-based nonprofit and a leading source of worldwide research funding on diseases of mind and sight, was recently awarded a Seal of Excellence from the Maryland Nonprofits Standards for Excellence Institute. This is the organization’s third time receiving this distinction.
In 2003, after his mother was diagnosed with Alzheimer’s, Microsoft co-founder Paul Allen put part of his fortune into brain research. What a fitting legacy for an “idea man,” whose philanthropy remains an inspiration.
The fall edition of the Alzheimer's Disease Research Review provides information on how improving brain blood flow could improve cognitive function in people who have Alzheimer's, the influence of genetics on Alzheimer's, a clinical trial examining the effects of physical activity on the dementia risk for older African Americans, and the uses and misuses of antipsychotic medications for managing challenging behaviors associated with Alzheimer's.
BrightFocus Foundation, a premier source of private research funding to defeat Alzheimer’s, macular degeneration, and glaucoma, has named two noted scientists to key positions within the non-profit organization.
New approaches to lowering eye pressure, a technique that may increase understanding of how glaucoma occurs, helpful information on how eye pressure is measured, lifestyle tips to promote eye health, and more are found in the fall 2018 edition of National Glaucoma Research Report.
On World Alzheimer’s Day, September 21, Stall Catchers will hold a global competition to boost Alzheimer’s research. Learn more about how to watch and even participate!
